Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan versus fluid restriction for hospitalised hypotonic hyponatraemia
ACTRN12619001683123Phase 3Completed
- Sponsor
- University of Melbourne
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tolvaptan in hyponatraemia, sponsored by University of Melbourne. Started May 2021; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on ACTRN12619001683123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001683123.